CNS-targeted glucocorticoid reduces pathology in mouse model of amyotrophic lateral sclerosis.

CNS-targeted glucocorticoid reduces pathology in mouse model of amyotrophic lateral sclerosis.

BACKGROUND: Hallmarks of CNS inflammation, including microglial and astrocyte activation, are prominent features in post-mortem tissue from amyotrophic lateral sclerosis (ALS) patients and in mice overexpressing mutant superoxide dismutase-1 (SOD1G93A). Administration of non-targeted glucocorticoids...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Evans, M, Gaillard, P, de Boer, M, Appeldoorn, C, Dorland, R, Sibson, N, Turner, M, Anthony, D, Stolp, H
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	2014

Eitemau Tebyg

CNS-TARGETED METHYLPREDNISOLONE REDUCES PATHOLOGY IN MOUSE MODEL OF ALS
gan: Stolp, H, et al.
Cyhoeddwyd: (2013)

Magnetic resonance imaging of pathological processes in rodent models of amyotrophic lateral sclerosis.
gan: Evans, M, et al.
Cyhoeddwyd: (2012)

Inflammation and neurovascular changes in amyotrophic lateral sclerosis.
gan: Evans, M, et al.
Cyhoeddwyd: (2013)

Inflammation and neurovascular changes in amyotrophic lateral sclerosis
gan: Evans, M, et al.
Cyhoeddwyd: (2013)

Amyotrophic lateral sclerosis.
gan: Kiernan, M, et al.
Cyhoeddwyd: (2011)

The reunification of amyotrophic lateral sclerosis
gan: Turner, M
Cyhoeddwyd: (2018)

Biomarkers in amyotrophic lateral sclerosis.
gan: Turner, M, et al.
Cyhoeddwyd: (2009)

Exploring neuroinflammatory processes in a mouse model of amyotrophic lateral sclerosis
gan: Evans, M, et al.
Cyhoeddwyd: (2012)

Neuroimaging in amyotrophic lateral sclerosis.
gan: Turner, M, et al.
Cyhoeddwyd: (2012)

Neuroimaging endpoints in amyotrophic lateral sclerosis
gan: Menke, R, et al.
Cyhoeddwyd: (2016)

The longitudinal cerebrospinal fluid metabolomic profile of amyotrophic lateral sclerosis.
gan: Gray, E, et al.
Cyhoeddwyd: (2015)

Untangling neuroinflammation in amyotrophic lateral sclerosis
gan: Thompson, AG, et al.
Cyhoeddwyd: (2019)

Advances in the application of MRI to amyotrophic lateral sclerosis.
gan: Turner, M, et al.
Cyhoeddwyd: (2010)

A wider pathological network underlying breathlessness and respiratory failure in amyotrophic lateral sclerosis
gan: Pattinson, KTS, et al.
Cyhoeddwyd: (2016)

Sweet food preference in amyotrophic lateral sclerosis
gan: Turner, M, et al.
Cyhoeddwyd: (2017)

The tough body at the epicentre of amyotrophic lateral sclerosis
gan: Turner, M, et al.
Cyhoeddwyd: (2017)

Defining pre-symptomatic amyotrophic lateral sclerosis
gan: Benatar, M, et al.
Cyhoeddwyd: (2019)

Imaging cerebral activity in amyotrophic lateral sclerosis
gan: Proudfoot, M, et al.
Cyhoeddwyd: (2019)

Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations.
gan: Bowser, R, et al.
Cyhoeddwyd: (2011)

Psychiatric disorders prior to amyotrophic lateral sclerosis
gan: Turner, M, et al.
Cyhoeddwyd: (2016)

Controversies and priorities in amyotrophic lateral sclerosis.
gan: Turner, M, et al.
Cyhoeddwyd: (2013)

Progress and new frontiers in biomarkers for amyotrophic lateral sclerosis
gan: Turner, M
Cyhoeddwyd: (2018)

Nerve fibre degeneration in the brain in amyotrophic lateral sclerosis.
gan: Turner, M
Cyhoeddwyd: (2012)

Quantitative FLAIR MRI in amyotrophic lateral sclerosis
gan: Fabes, J, et al.
Cyhoeddwyd: (2017)

Ensuring continued progress in biomarkers for amyotrophic lateral sclerosis.
gan: Turner, M, et al.
Cyhoeddwyd: (2015)

The genetics of amyotrophic lateral sclerosis
gan: Schymick, J
Cyhoeddwyd: (2009)

Myelin imaging in amyotrophic and primary lateral sclerosis.
gan: Kolind, S, et al.
Cyhoeddwyd: (2013)

Quantifying disease progression in amyotrophic lateral sclerosis.
gan: Simon, N, et al.
Cyhoeddwyd: (2014)

CSF chitinase proteins in amyotrophic lateral sclerosis
gan: Thompson, A, et al.
Cyhoeddwyd: (2019)

Motor system biomarkers in amyotrophic lateral sclerosis
gan: Edmond, EC, et al.
Cyhoeddwyd: (2019)

Lockhart Clarke's contribution to the description of amyotrophic lateral sclerosis.
gan: Turner, M, et al.
Cyhoeddwyd: (2010)

Survival motor neuron deficiency enhances progression in an amyotrophic lateral sclerosis mouse model.
gan: Turner, B, et al.
Cyhoeddwyd: (2009)

Defective cholesterol metabolism in amyotrophic lateral sclerosis.
gan: Abdel-Khalik, J, et al.
Cyhoeddwyd: (2016)

MRI as a frontrunner in the search for amyotrophic lateral sclerosis biomarkers?
gan: Turner, M
Cyhoeddwyd: (2011)

Mechanisms, models and biomarkers in amyotrophic lateral sclerosis.
gan: Turner, M, et al.
Cyhoeddwyd: (2013)

Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis.
gan: Menke, R, et al.
Cyhoeddwyd: (2014)

Assessment of the upper motor neuron in amyotrophic lateral sclerosis
gan: Huynh, W, et al.
Cyhoeddwyd: (2016)

TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy
gan: Turner, B, et al.
Cyhoeddwyd: (2008)

Does interneuronal dysfunction contribute to neurodegeneration in amyotrophic lateral sclerosis?
gan: Turner, M, et al.
Cyhoeddwyd: (2012)

Voxel-based MRI intensitometry reveals extent of cerebral white matter pathology in amyotrophic lateral sclerosis
gan: Hartung, V, et al.
Cyhoeddwyd: (2014)